WaveSense Jazz Blood Glucose Monitoring System— 510(k) K241304

Substantially Equivalent

Agamatrix

FDA 510(k) clearance K241304 for WaveSense Jazz Blood Glucose Monitoring System, Substantially Equivalent on 2024-06-06. Applicant: Agamatrix.

Clearance details

Applicant: Agamatrix
Product code: Code NBW
Advisory panel: Clinical Chemistry
Date received: 2024-05-09
Decision date: 2024-06-06
Decision: Substantially Equivalent
Clearance type: Special
Location: Salem, NH, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code NBW

product code NBW

Death: 18
Injury: 4,740
Malfunction: 42,679
Other: 6
Total: 47,443

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.